Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 481 AL 495

Alzheimer's Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles

Mota IFL, de Lima LS, Santana BM, Gobbo GAM, Bicca JVML, Azevedo JRM, Veras LG, Taveira RAA, Pinheiro GB, Mortari MR.

Neuroscientist. 2023 Feb;29(1):78-96. doi: 10.1177/10738584211016409. Epub 2021 May 21.

Whole-plant foods and their macromolecules: untapped approaches to modulate neuroinflammation in Alzheimer's disease

Huang R, Zhu Z, Wu Q, Bekhit AEA, Wu S, Chen M, Wang J, Ding Y.

Crit Rev Food Sci Nutr. 2023;63(15):2388-2406. doi: 10.1080/10408398.2021.1975093. Epub 2021 Sep 23.

Effects and mechanisms of natural products on Alzheimer's disease

Yang Z, Zhou DD, Huang SY, Fang AP, Li HB, Zhu HL.

Crit Rev Food Sci Nutr. 2023;63(18):3168-3188. doi: 10.1080/10408398.2021.1985428. Epub 2021 Oct 6.

Effects of repetitive paired associative stimulation on brain plasticity and working memory in Alzheimer's disease: a pilot randomized double-blind-controlled trial

Kumar S, Zomorrodi R, Ghazala Z, Goodman MS, Blumberger DM, Daskalakis ZJ, Fischer CE, Mulsant BH, Pollock BG, Rajji TK.

Int Psychogeriatr. 2023 Mar;35(3):143-155. doi: 10.1017/S1041610220003518. Epub 2020 Nov 16.

The Role of Hydrogen Sulfide in Regulation of Cell Death following Neurotrauma and Related Neurodegenerative and Psychiatric Diseases

Rodkin S, Nwosu C, Sannikov A, Raevskaya M, Tushev A, Vasilieva I, Gasanov M.

Int J Mol Sci. 2023 Jun 28;24(13):10742. doi: 10.3390/ijms241310742.

Natural products for the treatment of neurodegenerative diseases

Cui D, Chen Y, Ye B, Guo W, Wang D, He J.

Phytomedicine. 2023 Dec;121:155101. doi: 10.1016/j.phymed.2023.155101. Epub 2023 Sep 18.

Effect of arctigenin on neurological diseases: A review

Li M, Jiang H, Wang Y, Xu Z, Xu H, Chen Y, Zhu J, Lin Z, Zhang M.

J Ethnopharmacol. 2023 Oct 28;315:116642. doi: 10.1016/j.jep.2023.116642. Epub 2023 May 24.

Deep brain stimulation of fornix in Alzheimer's disease: From basic research to clinical practice

Liu Z, Shu K, Geng Y, Cai C, Kang H.

Eur J Clin Invest. 2023 Aug;53(8):e13995. doi: 10.1111/eci.13995. Epub 2023 Apr 10.

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Li L, Zhang J, Huang X, Du J, Tu Z, Wu H, Liu X, Yuan M.

Curr Pharm Des. 2023;29(2):95-115. doi: 10.2174/1381612829666221216114912.

Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies

Singh Gautam A, Pandey SK, Lasure V, Dubey S, Singh RK.

Expert Opin Biol Ther. 2023 Jul-Dec;23(7):603-618. doi: 10.1080/14712598.2023.2227378. Epub 2023 Jun 27.

Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment

Godse S, Zhou L, Sakshi S, Singla B, Singh UP, Kumar S.

Exp Biol Med (Maywood). 2023 Nov;248(22):2151-2166. doi: 10.1177/15353702231211863. Epub 2023 Dec 6.

Mitophagy: A promising therapeutic target for neuroprotection during ageing and age-related diseases

Mishra E, Thakur MK.

Br J Pharmacol. 2023 Jun;180(12):1542-1561. doi: 10.1111/bph.16062. Epub 2023 Mar 14.

Substance abuse and neurodegenerative diseases: focus on ferroptosis

Guo C, Chen L, Wang Y.

Arch Toxicol. 2023 Jun;97(6):1519-1528. doi: 10.1007/s00204-023-03505-4. Epub 2023 Apr 26.

Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review

Ortiz R, Rueda S, Di Ciano P.

Exp Clin Psychopharmacol. 2023 Oct;31(5):978-988. doi: 10.1037/pha0000659. Epub 2023 May 1.

Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders

Zheng Y, Bonfili L, Wei T, Eleuteri AM.

Nutrients. 2023 Oct 31;15(21):4631. doi: 10.3390/nu15214631.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias